Ming‐Yang Lai

762 total citations
18 papers, 667 citations indexed

About

Ming‐Yang Lai is a scholar working on Hepatology, Epidemiology and Molecular Biology. According to data from OpenAlex, Ming‐Yang Lai has authored 18 papers receiving a total of 667 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hepatology, 12 papers in Epidemiology and 3 papers in Molecular Biology. Recurrent topics in Ming‐Yang Lai's work include Hepatitis B Virus Studies (11 papers), Hepatitis C virus research (11 papers) and Liver Disease Diagnosis and Treatment (7 papers). Ming‐Yang Lai is often cited by papers focused on Hepatitis B Virus Studies (11 papers), Hepatitis C virus research (11 papers) and Liver Disease Diagnosis and Treatment (7 papers). Ming‐Yang Lai collaborates with scholars based in Taiwan, United States and Australia. Ming‐Yang Lai's co-authors include Ding‐Shinn Chen, Pei‐Jer Chen, Jia‐Horng Kao, Hui‐Ling Chen, Shiou‐Hwei Yeh, Chun‐Jen Liu, Guan‐Tarn Huang, Jin‐Chuan Sheu, Pei–Ming Yang and Yi‐Wen Huang and has published in prestigious journals such as Gastroenterology, Hepatology and Clinical Infectious Diseases.

In The Last Decade

Ming‐Yang Lai

18 papers receiving 650 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ming‐Yang Lai Taiwan	15	428	428	125	100	85	18	667
Toyoki Moribe∥ Japan	12	325 0.8×	383 0.9×	208 1.7×	181 1.8×	105 1.2×	22	750
Young Hwa Chung South Korea	9	203 0.5×	287 0.7×	98 0.8×	57 0.6×	145 1.7×	14	530
Douglas E. Ramsey United States	9	219 0.5×	527 1.2×	265 2.1×	65 0.7×	85 1.0×	13	1.1k
Hubert Darius J. Daniel India	13	295 0.7×	484 1.1×	293 2.3×	174 1.7×	231 2.7×	26	844
Hubert Perrin Monaco	7	222 0.5×	456 1.1×	74 0.6×	25 0.3×	71 0.8×	13	625
Martin Krüger Germany	12	240 0.6×	381 0.9×	301 2.4×	63 0.6×	193 2.3×	13	890
Shuji Nambu Japan	9	143 0.3×	232 0.5×	108 0.9×	79 0.8×	112 1.3×	18	484
Mustapha Benazzouz Morocco	12	147 0.3×	96 0.2×	128 1.0×	52 0.5×	78 0.9×	17	368
Hélène Mouly France	8	187 0.4×	114 0.3×	223 1.8×	47 0.5×	164 1.9×	14	475

Countries citing papers authored by Ming‐Yang Lai

Since Specialization

Citations

This map shows the geographic impact of Ming‐Yang Lai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming‐Yang Lai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming‐Yang Lai more than expected).

Fields of papers citing papers by Ming‐Yang Lai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming‐Yang Lai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming‐Yang Lai. The network helps show where Ming‐Yang Lai may publish in the future.

Co-authorship network of co-authors of Ming‐Yang Lai

This figure shows the co-authorship network connecting the top 25 collaborators of Ming‐Yang Lai. A scholar is included among the top collaborators of Ming‐Yang Lai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming‐Yang Lai. Ming‐Yang Lai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Huang, Yi‐Wen, Kazuaki Chayama, Masataka Tsuge, et al.. (2010). Differential effects of interferon and lamivudine on serum HBV RNA inhibition in patients with chronic hepatitis B. Antiviral Therapy. 15(2). 177–184. 42 indexed citations

Su, Tung‐Hung, Ching‐Sheng Hsu, Chi‐Ling Chen, et al.. (2010). Serum hepatitis B surface antigen concentration correlates with HBV DNA level in patients with chronic hepatitis B. Antiviral Therapy. 15(8). 1133–1139. 76 indexed citations

Huang, Yi‐Wen, Chung‐Yi Hu, Ya-Tang Liao, et al.. (2009). Human leukocyte antigen‐DRB1*1101 correlates with less severe hepatitis in Taiwanese male carriers of hepatitis B virus. Journal of Medical Virology. 81(4). 588–593. 5 indexed citations

Liu, Wei‐Liang, et al.. (2009). Ribavirin enhances interferon signaling via stimulation of mTOR and p53 activities. FEBS Letters. 583(17). 2793–2798. 19 indexed citations

Tsai, Ya‐Hui, Tsai-Yi Lu, Jia‐Horng Kao, et al.. (2008). The non-structural 5A protein of hepatitis C virus exhibits genotypic differences in interferon antagonism. Journal of Hepatology. 49(6). 899–907. 18 indexed citations

Veenstra, David L., et al.. (2007). HBeAg-Negative Chronic Hepatitis B: Cost-Effectiveness of Peginterferon Alfa-2a Compared to Lamivudine in Taiwan. Value in Health. 11(2). 131–138. 18 indexed citations

Huang, Yi‐Wen, Chun‐Jen Liu, Ming‐Yang Lai, et al.. (2006). Discontinuation of lamivudine treatment for hepatitis flare after kidney or heart transplantation in hepatitis B surface antigen-positive patients: A retrospective case series. Clinical Therapeutics. 28(9). 1327–1334. 5 indexed citations

Liu, Chun‐Jen, Ming‐Yang Lai, You‐Chen Chao, et al.. (2006). Interferon α‐2b with and without ribavirin in the treatment of hepatitis B e antigen–positive chronic hepatitis B. Hepatology. 43(4). 742–749. 36 indexed citations

Huang, Yi‐Wen, Chih‐Lin Lin, Pei‐Jer Chen, et al.. (2006). Higher cut‐off index value of immunoglobulin M antibody to hepatitis B core antigen in Taiwanese patients with hepatitis B. Journal of Gastroenterology and Hepatology. 21(5). 859–862. 15 indexed citations

10.

Shih, Yung‐Feng, et al.. (2005). Fundus abnormalities in a patient with type I Gaucher's disease with 12-year follow-up. American Journal of Ophthalmology. 139(2). 359–362. 8 indexed citations

11.

Lin, Chih‐Lin, Li‐Ying Liao, Chaur‐Shine Wang, et al.. (2004). Evolution of hepatitis B virus precore/basal core promoter gene in HBeAg‐positive chronic hepatitis B patients receiving lamivudine therapy. Liver International. 24(1). 9–15. 16 indexed citations

12.

Hassanein, Tarek, Graham Cooksley, Mark Sulkowski, et al.. (2004). The impact of peginterferon alfa-2a plus ribavirin combination therapy on health-related quality of life in chronic hepatitis C. Journal of Hepatology. 40(4). 675–681. 89 indexed citations

13.

Yeh, Shiou-Hwei, Ming‐Wei Lin, Shih-Feng Tsai, et al.. (2004). Allelic loss of chromosome 4q21 ≈ 23 associates with hepatitis B Virus—related hepatocarcinogenesis and elevated alpha-fetoprotein. Hepatology. 40(4). 847–854. 20 indexed citations

14.

Tsang, Yuk‐Ming, Po‐Ren Hsueh, Guan‐Tarn Huang, et al.. (1999). Bacterial Infections Associated with Hepatic Arteriography and Transarterial Embolization for Hepatocellular Carcinoma: A Prospective Study. Clinical Infectious Diseases. 29(1). 161–166. 21 indexed citations

15.

Chen, Pei‐Jer, Ming‐Yang Lai, Ding‐Shinn Chen, et al.. (1994). Inverse polymerase chain reaction for cloning cellular sequences adjacent to integrated hepatitis B virus DNA in hepatocellular carcinomas. Journal of Virological Methods. 49(3). 269–284. 28 indexed citations

16.

Yeh, Shiou‐Hwei, et al.. (1994). Frequent genetic alterations at the distal region of chromosome 1p in human hepatocellular carcinomas.. PubMed. 54(15). 4188–92. 114 indexed citations

17.

Chen, Pei‐Jer, Ding‐Shinn Chen, Ming‐Yang Lai, et al.. (1989). Clonal Origin of Recurrent Hepatocellular Carcinomas. Gastroenterology. 96(2). 527–529. 113 indexed citations

18.

Lai, Ming‐Yang, Ding‐Shinn Chen, Pei‐Jer Chen, et al.. (1988). Status of hepatitis B virus DNA in hepatocellular carcinoma: A study based on paired tumor and nontumor liver tissues. Journal of Medical Virology. 25(3). 249–258. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact